Related Experiment Video
Updated: Mar 30, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
A meta-analysis of mitral valve repair versus replacement for ischemic mitral regurgitation
Sohaib A Virk1, Arunan Sriravindrarajah1, Douglas Dunn1
11 The Systematic Review Unit, The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia ; 2 Department of Cardiology, 3 Department of Cardiothoracic Surgery, Prince of Wales Hospital, Sydney, Australia.
Background:
The development of ischemic mitral regurgitation (IMR) portends a poor prognosis and is associated with adverse long-term outcomes. Although both mitral valve repair (MVr) and mitral valve replacement (MVR) have been performed in the surgical management of IMR, there remains uncertainty regarding the optimal approach. The aim of the present study was to meta-analyze these two procedures, with mortality as the primary endpoint.
Methods:
Seven databases were systematically searched for studies reporting peri-operative or late mortality following MVr and MVR for IMR. Data were independently extracted by two reviewers and meta-analyzed according to pre-defined study selection criteria and clinical endpoints.
Results:
Overall, 22 observational studies (n=3,815 patients) and one randomized controlled trial (n=251) were included. Meta-analysis demonstrated significantly reduced peri-operative mortality [relative risk (RR) 0.61; 95% confidence intervals (CI), 0.47-0.77; I(2)=0%; P<0.001] and late mortality (RR, 0.78; 95% CI, 0.67-0.92; I(2)=0%; P=0.002) following MVr. This finding was more pronounced in studies with longer follow-up beyond 3 years. At latest follow-up, recurrence of at least moderate mitral regurgitation (MR) was higher following MVr (RR, 5.21; 95% CI, 2.66-10.22; I(2)=46%; P<0.001) but the incidence of mitral valve re-operations were similar.
Conclusions:
In the present meta-analysis, MVr was associated with reduced peri-operative and late mortality compared to MVR, despite an increased recurrence of at least moderate MR at follow-up. However, these findings must be considered within the context of the differing patient characteristics that may affect allocation to MVr or MVR. Larger prospective studies are warranted to further compare long-term survival and freedom from re-intervention.
Insights
Mitral valve repair (MVr) for ischemic mitral regurgitation (IMR) reduces peri-operative and late mortality compared to mitral valve replacement (MVR). However, MVr is associated with a higher recurrence of moderate mitral regurgitation.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Research
Background:
- Ischemic mitral regurgitation (IMR) is linked to poor prognosis and adverse long-term outcomes.
- Surgical management of IMR includes mitral valve repair (MVr) and mitral valve replacement (MVR), with ongoing debate regarding the optimal approach.
Purpose of the Study:
- To conduct a meta-analysis comparing MVr and MVR for IMR, with mortality as the primary endpoint.
Main Methods:
- Systematic search of seven databases for studies on peri-operative or late mortality following MVr and MVR for IMR.
- Independent data extraction by two reviewers and meta-analysis of selected studies.
Main Results:
- Meta-analysis of 22 observational studies and one RCT (3,815 patients) showed significantly reduced peri-operative mortality (RR 0.61) and late mortality (RR 0.78) with MVr.
- The benefits of MVr on mortality were more pronounced in studies with follow-up exceeding 3 years.
- Higher recurrence of at least moderate mitral regurgitation (MR) was observed with MVr (RR 5.21), while mitral valve re-operation rates were similar.
Conclusions:
- Mitral valve repair (MVr) is associated with reduced peri-operative and late mortality compared to mitral valve replacement (MVR) for IMR.
- Despite increased MR recurrence with MVr, similar re-operation rates were noted.
- Further large prospective studies are needed to fully compare long-term survival and re-intervention rates, considering patient characteristics influencing treatment allocation.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management

